Status:
TERMINATED
Mesothelioma Early Detection by VOCs
Lead Sponsor:
Henry Ford Health System
Collaborating Sponsors:
International Association of Heat and Frost Insulators and Allied Workers
Owlstone Ltd
Conditions:
Pleural Mesothelioma
Asbestos Exposure
Eligibility:
All Genders
18+ years
Brief Summary
This is a two phase study, The first phase (phase 1) will identify potential biomarkers among asbestos exposed individuals with pleural mesothelioma. The second phase (phase 2), is a double blinded ca...
Detailed Description
Mesothelioma is a rare, aggressive and treatment-resistant disease and, in the United States, is caused almost exclusively by exposure to asbestos fibers. There is often a lengthy latency period of 40...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Male or Female over 18 years of age
- Clinical diagnosis of pleural mesothelioma or presence of pleural plaques on X-Ray
- Documented exposure to asbestos
- Must be able to provide breath sample
- Must be able to provide relevant medical information
- Exclusion Criteria
- Presence of malignancies other that mesothelioma within the past 6 months
- Treatment for any malignancies other than mesothelioma within the past 6 months
- Inability to provide past clinical information
- Inability to perform breath collection procedure
- Smoking or consuming alcohol within two hours of conducting breath collection procedure
Exclusion
Key Trial Info
Start Date :
June 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04106973
Start Date
June 5 2019
End Date
January 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Consultants in Sleep and Pulmonary Medicine
Farmington Hills, Michigan, United States, 48336